Hye-Mi Kim
Research Subjects
Research Interests
Hye-Mi Kim has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Do-Youn Jeong
Microbial Institute for Fermentation Industry (MIFI), Sunchang-gun 56048, Republic of Korea
1 shared publication - Hyang-Im Baek
Department of Food Science & Nutrition, Woosuk University, Wanju 55338, Republic of Korea
1 shared publication - Ki-Chan Ha
Healthcare Claims & Management Incorporation, 758 Baekie-daero, Deokin-gu, Jeonju, Jeonbuk 561-832, Republic of Korea
1 shared publication - Min-Gul Kim
Jeonbuk National University Medical School, Jeonju, Republic of Korea
1 shared publication - Moon-Sun Byun
Department of Food Science and Human Nutrition, Chonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk 561-756, Republic of Korea
1 shared publication - Ok-Kyeong Yu
Department of Obesity Research Center, Chonbuk National University, Jeonju 54896, Korea
1 shared publication
Latest Publications
- Open Access
- 31 October 2013
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 13 (1) , 297
The influence of the Korean traditional Chungkookjang on variables of metabolic syndrome in overweight/obese subjects: study protocol
Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease. The primary target of treatment of patients with metabolic syndrome is therapeutic lifestyle change. Numerous preclinical study have reported positive effects of chungkookjang in in vivo models of diabetes and obesity, but there is a paucity of controlled clinical trials on variables of metabolic syndrome in obese subjects. Thus, the objective of this trial is to examine the effect of chungkookjang compared to placebo on variables of metabolic syndrome in overweight/obese subjects.
- 31 October 2013
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 13 (1) , 297
Open AccessThe influence of the Korean traditional Chungkookjang on variables of metabolic syndrome in overweight/obese subjects: study protocol
Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease. The primary target of treatment of patients with metabolic syndrome is therapeutic lifestyle change. Numerous preclinical study have reported positive effects of chungkookjang in in vivo models of diabetes and obesity, but there is a paucity of controlled clinical trials on variables of metabolic syndrome in obese subjects. Thus, the objective of this trial is to examine the effect of chungkookjang compared to placebo on variables of metabolic syndrome in overweight/obese subjects.